Novartis will be going to the Supreme Court in India to seek protection in form of patent for its cancer drug Glivec. Read more here. According to health campaigners in India, if Novartis is to win the case, it would mean handing down a ‘death sentence’ to the poor and ill in the developing world (read here). Read more here.